Primary prevention of coronary heart disease - Integrating risk assessment with intervention
Primary prevention of coronary heart disease - Integrating risk assessment with intervention
复制标题
DOI:
10.1161/01.cir.100.9.988
复制
发表时间:
1999-08-31
期刊:
影响因子:
37.8
通讯作者:
Grundy, SM
中科院分区:
文献类型:
--
作者:
Grundy, SM
lowering trials provides 1 example. Patients on placebo of the Cholesterol and Recurrent Events (CARE) study9 and the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) study, 10 who should be representative of American patients with CHD, had a projected 10-year risk for major coronary events of 26%. A related standard could be the patient with stable angina pectoris; recent analyses16, 17 project an average risk of fatal or nonfatal myocardial infarction in patients with stable angina to be 20% in 10 years. Thus, for primary prevention, a high short-term risk might be defined as a probability of developing a fatal or nonfatal myocardial infarction of 20% in the next 10 years. High risk for CHD in the short term can be identified by the presence of clinical atherosclerotic disease in other arterial beds, by the presence of subclinical atherosclerosis, or by multiple risk factors. High risk in the long term can be defined by an elevated risk for CHD over a longer period (10 years) or even over a lifetime. 18 Several risk factors may contribute to a high long-term risk, but even single risk factors, if left untreated for many years, can hasten the onset of CHD. Thus, patients with single or multiple categorical risk factors should not be ignored by their physicians; primary prevention is for the long term as well as the short term. Patients at high risk in the long term deserve risk reduction under medical supervision. Finally, a lower risk can be ascribed to patients who are largely devoid of risk factors. For instance, investigators of the Framingham Heart Study19 recently defined low-risk individuals as being nonsmoking, nondiabetic persons who have a desirable level of LDL cholesterol (100 to 129 mg/dL), an optimal blood pressure (120/80 mm Hg), and a relatively high HDL cholesterol (45 mg/dL for men and 55 mg/dL for women). Even persons who are at low risk by these criteria deserve some attention by physicians. Periodic monitoring is needed to assess whether risk status has changed. Also, because absolute risk rises with advancing age, riskreduction messages should be conveyed to low-risk persons in accord with the public health effort to reduce risk in the general population.Relative risk is the ratio of 2 levels of absolute risk. The numerator is the absolute risk of the individual under consideration; the denominator is the average absolute risk of a baseline population, ie, either a low-risk group or an averagerisk group. The low-risk state, as defined by Framingham investigators, 19 makes an attractive denominator for evaluating the impact of risk factors in given individuals. Estimates of relative risk carry certain advantages in risk assessment. For instance, a high relative risk in a young adult signifies a high level of absolute risk over the long term; such may call for early, intensified risk reduction. Moreover, because of a rising absolute risk with advancing age, a high relative risk after age 65 signifies a particularly high absolute risk and suggests the need for more aggressive intervention on risk factors.